The effect of coenzyme <scp>Q10</scp> supplementation on liver enzymes: A systematic review and meta‐analysis of randomized clinical trials

Soleimani Damaneh, Mohadeseh; Fatahi, Somaye; Aryaeian, Naheed; Bavi Behbahani, Hossein

doi:10.1002/fsn3.3478

Cited by 3 publications

(1 citation statement)

References 80 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Liver, which is the largest internal organ in the human body, plays a crucial role in several metabolic activities such as detoxification, energy storage, and synthesis of cholesterol. The aforementioned processes necessitate a substantial quantity of energy, and CoQ10 serves as a vital constituent in the electron transport chain, a crucial mechanism responsible for the generation of energy within hepatocytes (14). In addition, it has been observed that CoQ10 has hepatoprotective properties, thereby contributing to the mitigation and management of hepatic disorders, including fatty liver and hepatitis (15).…”

Section: Coq10 Presence In Organs With Higher Energy Demandsmentioning

confidence: 99%

Coenzyme Q10: A Ubiquitous Supplemental Enzyme Contributing to the Health

Silić

2023

Sci Insights

View full text Add to dashboard Cite

Coenzyme Q10 (CoQ10) is an endogenous molecule that is ubiquitously found throughout the cellular composition of the human organism. The aforementioned substance plays a crucial function in the production of energy and serves as a potent antioxidant, safeguarding cells against harm induced by free radicals. As individuals progress in age, there is a tendency for the amounts of CoQ10 in their bodies to diminish, resulting in a range of health consequences. Research has indicated that the addition of CoQ10 through supplementation can yield a multitude of advantageous outcomes. Research has demonstrated that it can enhance energy production in cardiac cells and mitigate oxidative stress, so contributing to the improvement of heart health. Furthermore, CoQ10 has demonstrated potential in the management of several illnesses such as hypertension, migraines, and fibromyalgia, attributed to its capacity to enhance mitochondrial activity and alleviate inflammation. Moreover, existing research indicates that the utilization of this particular coenzyme may potentially enhance fertility through the improvement of sperm quality, as well as contribute to the maintenance of good skin by facilitating collagen synthesis. Notwithstanding these possible advantages, it is essential to get guidance from a healthcare practitioner prior to commencing any supplementation protocol due to the potential variability of individual requirements.

show abstract

Section: Coq10 Presence In Organs With Higher Energy Demandsmentioning

confidence: 99%

Coenzyme Q10: A Ubiquitous Supplemental Enzyme Contributing to the Health

Silić

2023

Sci Insights

View full text Add to dashboard Cite

show abstract

Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease

Hussein,

Nema,

Nasir

2024

Open Life Sciences

View full text Add to dashboard Cite

Non-alcoholic fatty liver disease (NAFLD), characterized by hepatic fat accumulation in individuals consuming little or no alcohol, has become highly prevalent globally. Oxidative stress plays a central role in instigating inflammation and cell death pathways driving NAFLD progression. This case–control study aimed to elucidate the association between circulating levels of the pivotal non-enzymatic antioxidants – coenzyme Q10 and vitamins E and C – and liver injury parameters among 60 Iraqi NAFLD patients versus 30 healthy controls. NAFLD diagnosis entailed over 5% hepatic steatosis on ultrasound excluding other etiologies. Patients spanned three age groups: 20–29, 30–39, and 40–49. Substantially diminished antioxidant levels concurrent with elevated alkaline phosphatase enzyme were unveiled in NAFLD patients relative to controls (all p < 0.001). Age-based analysis reinforced widespread antioxidant depletion and liver enzyme augmentation across NAFLD patients. Significant correlations also emerged between antioxidants and liver parameters. Our novel observations confirm an antioxidant inadequacy likely perpetuating pathogenic oxidative reactions in NAFLD. Restoring such deficits through lifestyle or therapeutic interventions may confer preventative and disease-modifying value.

show abstract

Comparative Assessment of Beeswax Alcohol and Coenzyme Q10 (CoQ10) to Prevent Liver Aging, Organ Damage, and Oxidative Stress in Hyperlipidemic Zebrafish Exposed to D-Galactose: A 12-Week Dietary Intervention

Cho,

Bahuguna,

Kim

et al. 2024

Pharmaceuticals

View full text Add to dashboard Cite

The current study was designed to compare in vivo efficacy between beeswax alcohol (BWA) and coenzyme Q10 (CoQ10) to treat fatty liver changes, oxidative stress, and damages in major organs of zebrafish by 12 weeks with high-cholesterol (HC) and galactose (Gal) supplementation. At week 12, the HC control and HC+Gal control groups showed 96% and 92% survivability, respectively, while co-supplementation of the 0.5% BWA and 1.0% BWA groups exhibited 96% and 100% survivability. However, co-supplementation of the 0.5% CoQ10 and 1.0% CoQ10 groups revealed the lowest survivability, around 92% and 89%, respectively. The 0.5% BWA and 1.0% BWA groups showed 21% (p < 0.001) and 41% (p < 0.001), respectively, lower total cholesterol (TC) than the HC+Gal control, while the 1.0% CoQ10 group showed only 15% lower TC than the control. Interestingly, the 0.5% BWA and 1.0% BWA groups showed 22% (p < 0.001) and 38% (p < 0.001), respectively, lower triglyceride (TG) than the HC+Gal control. However, both the 0.5% CoQ10 and 1.0% CoQ10 groups showed similar TG levels as the control, suggesting that CoQ10 supplementation had no effect on lowering serum TG. The 1.0% BWA group showed the highest plasma HDL-C and HDL-C/TC (%) up to 3.2-fold and 5.5-fold, respectively, higher than those of the HC+Gal control, while the 1.0% CoQ10 group showed 2.4-fold and 2.8-fold higher plasma HDL-C and HDL-C/TC (%), respectively, than the control. The plasma aspartate transaminase (AST) and alanine transaminase (ALT) levels were lowest in the 1.0% BWA group, 51% and 72%, respectively, lower than HC+Gal control, suggesting the lowest extent of hepatic damage. In hepatic tissue, neutrophil infiltration and interleukin (IL)-6 production were the lowest in the 1.0% BWA group, around 67% and 85%, respectively, lower than the HC+Gal control. Fatty liver change, cellular apoptosis, and cell senescence in hepatic tissue were remarkably lowered in the 1.0% BWA group, while the CoQ10 group showed much less effect than the BWA group. In kidney, ovary, and testis tissue, the 1.0% BWA group showed the lowest production of reactive oxygen species, the extent of cellular senescence, and cellular apoptosis with the healthiest cell morphology. In conclusion, supplementation of BWA remarkably protected the liver, kidney, ovary, and testis from oxidative damage by cholesterol and galactose consumption, with the least serum AST and ALT levels, inflammatory parameters, and senescence markers.

show abstract

The effect of coenzyme Q10 supplementation on liver enzymes: A systematic review and meta‐analysis of randomized clinical trials

Cited by 3 publications

References 80 publications

Coenzyme Q10: A Ubiquitous Supplemental Enzyme Contributing to the Health

Coenzyme Q10: A Ubiquitous Supplemental Enzyme Contributing to the Health

Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease

Comparative Assessment of Beeswax Alcohol and Coenzyme Q10 (CoQ10) to Prevent Liver Aging, Organ Damage, and Oxidative Stress in Hyperlipidemic Zebrafish Exposed to D-Galactose: A 12-Week Dietary Intervention

Contact Info

Product

Resources

About